Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2013 (2013), Article ID 150278, 2 pages
http://dx.doi.org/10.1155/2013/150278
Case Report

Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy

12nd Department of Obstetrics and Gynecology, Medical School of Athens, Aretaieion University Hospital, Vas. Sofias Avenue, 11528 Athens, Greece
21st Department of Anesthesiology, Medical School of Athens, Aretaieion University Hospital, Vas. Sofias Avenue, 11528 Athens, Greece

Received 16 June 2013; Accepted 27 August 2013

Academic Editors: K. Dafopoulos, P. De Franciscis, S.-Y. Ku, and M. Origoni

Copyright © 2013 Charalampos Grigoriadis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Alpha-methyldopa has been demonstrated to be safe for use during pregnancy and is now used to treat gestational hypertension. In pregnancy, alpha-methyldopa-induced autoimmune hemolytic anemia does not have typical features and the severity of symptoms ranges from mild fatigue to dyspnea, respiratory failure, and death if left untreated. A case of alpha-methyldopa-induced autoimmune hemolytic anemia in a 36-year-old gravida 2, para 1 woman at 37+6 weeks of gestation is reported herein along with the differential diagnostic procedure and the potential risks to the mother and the fetus.